Multiple functions of HMGB1 in cancer

作者：Guangyao Lv, Meng‐Lin Yang, Keke Gai, Qiong Jia, Zhenzhen Wang, Bin Wang, Xueying Li · 发表于：Frontiers in Oncology · 年份：2024 · DOI：10.3389/fonc.2024.1384109 · 被引用次数：44 · 研究领域：Advanced Glycation End Products research、Immune cells in cancer、Inflammatory mediators and NSAID effects

High mobility group box 1 (HMGB1) is a nuclear DNA-binding protein with a dual role in cancer, acting as an oncogene and a tumor suppressor. This protein regulates nucleosomal structure, DNA damage repair, and genomic stability within the cell, while also playing a role in immune cell functions. This review comprehensively evaluates the biological and clinical significance of HMGB1 in cancer, including its involvement in cell death and survival, its potential as a therapeutic target and cancer biomarker, and as a prosurvival signal for the remaining cells after exposure to cytotoxic anticancer treatments. We highlight the need for a better understanding of the cellular markers and mechanisms involved in the involvement of HMGB1in cancer, and aim to provide a deeper understanding of its role in cancer progression.